SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-145661
Filing Date
2022-05-10
Accepted
2022-05-10 07:08:06
Documents
14
Period of Report
2022-05-09
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d336582d8k.htm   iXBRL 8-K 40629
2 EX-99.1 d336582dex991.htm EX-99.1 44413
  Complete submission text file 0001193125-22-145661.txt   256949

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA pfe-20220509.xsd EX-101.SCH 4107
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pfe-20220509_def.xml EX-101.DEF 13212
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pfe-20220509_lab.xml EX-101.LAB 21830
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pfe-20220509_pre.xml EX-101.PRE 14108
8 EXTRACTED XBRL INSTANCE DOCUMENT d336582d8k_htm.xml XML 5231
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-03619 | Film No.: 22907323
SIC: 2834 Pharmaceutical Preparations